GB9523566D0 - Pharmaceutical formulation - Google Patents

Pharmaceutical formulation

Info

Publication number
GB9523566D0
GB9523566D0 GBGB9523566.9A GB9523566A GB9523566D0 GB 9523566 D0 GB9523566 D0 GB 9523566D0 GB 9523566 A GB9523566 A GB 9523566A GB 9523566 D0 GB9523566 D0 GB 9523566D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9523566.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Euro Celtique SA
Original Assignee
Euro Celtique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique SA filed Critical Euro Celtique SA
Priority to GBGB9523566.9A priority Critical patent/GB9523566D0/en
Publication of GB9523566D0 publication Critical patent/GB9523566D0/en
Priority to AU75826/96A priority patent/AU7582696A/en
Priority to PCT/GB1996/002824 priority patent/WO1997018801A1/en
Pending legal-status Critical Current

Links

GBGB9523566.9A 1995-11-17 1995-11-17 Pharmaceutical formulation Pending GB9523566D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9523566.9A GB9523566D0 (en) 1995-11-17 1995-11-17 Pharmaceutical formulation
AU75826/96A AU7582696A (en) 1995-11-17 1996-11-15 Pharmaceutical formulation
PCT/GB1996/002824 WO1997018801A1 (en) 1995-11-17 1996-11-15 Pharmaceutical formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9523566.9A GB9523566D0 (en) 1995-11-17 1995-11-17 Pharmaceutical formulation

Publications (1)

Publication Number Publication Date
GB9523566D0 true GB9523566D0 (en) 1996-01-17

Family

ID=10784062

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9523566.9A Pending GB9523566D0 (en) 1995-11-17 1995-11-17 Pharmaceutical formulation

Country Status (3)

Country Link
AU (1) AU7582696A (en)
GB (1) GB9523566D0 (en)
WO (1) WO1997018801A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060029653A1 (en) 1997-01-29 2006-02-09 Cronk Peter J Therapeutic delivery system
DE19807535A1 (en) * 1998-02-21 1999-08-26 Asta Medica Ag Drug combination for treating migraine, migraine-type headaches or pain accompanied by nausea, vomiting or delayed gastric emptying
JP5042425B2 (en) * 2000-03-01 2012-10-03 ユーロセルティック ソシエテ アノニム Tramadol for the treatment of functional gastrointestinal diseases
KR100406352B1 (en) * 2001-03-29 2003-11-28 삼성전기주식회사 Antenna and method for manufacture thereof
CN1332664C (en) * 2002-04-26 2007-08-22 中国人民解放军军事医学科学院毒物药物研究所 Snuff
CA2662018A1 (en) 2006-08-30 2008-03-06 David William Smith Method of imparting a mono-axial or multiaxial stiffness to extruded materials and products resulting therefrom
JP2010522135A (en) 2006-10-09 2010-07-01 チャールストン ラボラトリーズ，インコーポレイテッド Pharmaceutical composition
EP2240022B1 (en) * 2008-01-09 2016-12-28 Charleston Laboratories, Inc. Bilayered tablets comprising oxycodone and promethazine
CA2767576C (en) 2009-07-08 2020-03-10 Charleston Laboratories Inc. Pharmaceutical compositions comprising an antiemetic and an opioid analgesic
CN106413717A (en) * 2014-04-10 2017-02-15 查尔斯顿实验室公司 Pharmaceutical compositions
JP2019507181A (en) 2016-03-04 2019-03-14 チャールストン ラボラトリーズ，インコーポレイテッド Pharmaceutical composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0534628B1 (en) * 1991-09-06 1996-11-20 Mcneilab, Inc. Compositions comprising a tramadol material and any of codeine, oxycodone or hydrocodone, and their use

Also Published As

Publication number Publication date
AU7582696A (en) 1997-06-11
WO1997018801A1 (en) 1997-05-29

Similar Documents

Publication Publication Date Title
GB9519363D0 (en) Pharmaceutical formulation
EG23826A (en) Pharmaceutical formulations
AP9600883A0 (en) Pharmaceutical formulations
GB9407386D0 (en) Pharmaceutical formulation
GB9402203D0 (en) Pharmaceutical formulation
IL112521A0 (en) Pharmaceutical formulation
ZA965368B (en) A pharmaceutical formulation
EP0862431A4 (en) Pharmaceutical formulation
ZA96124B (en) A pharmaceutical formulation
GB9405856D0 (en) Pharmaceutical formulation
GB9416599D0 (en) Pharmaceutical formulation
GB9523566D0 (en) Pharmaceutical formulation
GB9502695D0 (en) Pharmaceutical composition
ZA96526B (en) Novel pharmaceutical formulation
AP9801196A0 (en) Pharmaceutical preparation
ZA964372B (en) A pharmaceutical formulation
ZA965367B (en) A pharmaceutical formulation
ZA96122B (en) A pharmaceutical formulation
ZA96392B (en) Pharmaceutical formulations
GB9418550D0 (en) Drug formulation
ZA967542B (en) Pharmaceutical combination preparation comprising keto-profen
GB9500978D0 (en) Pharmaceutical formulations
GB9502786D0 (en) Pharmaceutical formulation
GB9525386D0 (en) Pharmaceutical formulation
HUP9602732A2 (en) Pharmaceutical composition comprising lanperisone